Evaluating the Pharmacokinetic Characteristics of AD-102 in Healthy Volunteers

NCT03824171 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

52

Enrollment

INDUSTRY

Sponsor class

Conditions

Osteoporosis

Interventions

DRUG: Raloxifene 60mg/Cholecalciferol 800IU
DRUG: AD-102

Sponsor

Addpharma Inc.